Stock overview
Beam Therapeutics Inc
Explore the company, reported ownership, price history, and available source evidence.
Beam Therapeutics Inc (BEAM) is a healthcare or biotechnology equity security tracked from 13F filings.
- Last close
- $24.27
- · BEAM
- Tracked holders
- 5 funds
- Latest available 13F per fund
BEAM · USD
Price
$24.27
-$6.76
(-21.79%)
over selected range
Close · Sep 25, 2026
Market open
23 stored daily closes
$24.27
Sep 25, 2026
- Range low
- $23.10
- Range high
- $31.03
- Observations
- 23
- Session date
- Sep 25, 2026
Aug 25, 2026–Sep 25, 2026. Regular market hours only. Historical prices are unadjusted; splits and other corporate actions can affect comparisons.
Investor Popularity
Rows are narrowed by movement, fund type, and position size.
| Fund | Move | Value | Weight |
|---|---|---|---|
| ARK Investment Management largest tracked holder Q2 2026 · filed Aug 14, 2026 · SEC filing | −16% 26'Q2 | $351,260,447 | 2.28% |
| Renaissance Technologies position history Q2 2026 · filed Aug 13, 2026 · SEC filing | −13% 26'Q2 | $15,272,400 | 0.02% |
| Duquesne Family Office position history Q2 2026 · filed Aug 14, 2026 · SEC filing | Newly reported 26'Q2 | $5,272,000 | 0.1% |
| Tudor Investment Corp position history Q2 2026 · filed Aug 14, 2026 · SEC filing | +4% 26'Q2 | $1,684,837 | 0% |
| Gotham Asset Management position history Q2 2026 · filed Aug 14, 2026 · SEC filing | Newly reported 26'Q2 | $367,910 | 0% |
SEC Forms 4/5
Insiders
Financials
Official-source analysis
AI Earnings Report
No published AI Earnings Report yet
We publish a cited AI Earnings Report after an eligible official earnings filing is accepted and passes validation.
Options market